Effect of a Mindfulness-Based Stress Reduction Program on Hot Flashes and Sleep Quality in Menopausal Women: A Randomized Controlled Trial
- Sponsor
- Inonu University
- Study ID
- NCT07402096
- Status
- Not Yet Recruiting
Notify me when recruiting opens
Save your spot on the interest list for this study. We'll keep your details with this study so our team can follow up when recruiting opens.
Add your contact details and location so we can keep your interest tied to this study.
Conditions
- Hot Flashes
- Menopause
- Sleep Wake Disorders
Eligibility Criteria
- Sex
- MALE
- Age
- 45 Years - 60 Years
- Healthy Volunteers
- Accepted
Interventions
- Mindfulness-Based Stress Reduction (MBSR) — BEHAVIORALMindfulness-Based Stress Reduction (MBSR) is a structured behavioral intervention consisting of an 8-week program with weekly sessions lasting 60-90 minutes. The program includes mindfulness practices such as breathing awareness, body scan, emotional awareness, stress response awareness, and mindfulness in daily life. Sessions are delivered through a combination of face-to-face and online formats.
Study Details
Menopause is a natural transition characterized by vasomotor symptoms such as hot flashes and sleep disturbances, which can significantly impair quality of life. Non-pharmacological interventions are increasingly recommended for women who cannot or prefer not to use hormone therapy. Mindfulness-Based Stress Reduction (MBSR) is a structured behavioral intervention that has shown beneficial effects on stress-related symptoms and sleep quality; however, evidence regarding its effects on menopausal symptoms remains limited. This randomized controlled trial aims to evaluate the effectiveness of an 8-week MBSR program on hot flash frequency and severity and sleep quality in menopausal women. A total of 90 menopausal women will be randomly assigned to either an intervention group receiving the MBSR program or a control group receiving no intervention. Participants in the intervention group will attend weekly sessions and engage in mindfulness practices, including breathing awareness, body scan, and stress management techniques. Primary outcomes include changes in hot flash frequency and severity and sleep quality, assessed using validated self-report measures. The findings of this study are expected to contribute to evidence-based, non-pharmacological management strategies for menopausal symptoms.
Key Dates
- First listed
- Feb 11, 2026
- Start date
- May 15, 2026
- Status verified
- Feb 2026
- Primary completion
- Sep 30, 2026
- Completion
- Dec 31, 2026
Study Design
- Enrollment
- 90 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- TREATMENT
Arms
- Experimental: Mindfulness-Based Stress Reduction (MBSR) GroupParticipants in this arm will receive an 8-week Mindfulness-Based Stress Reduction (MBSR) program. The program consists of weekly sessions lasting 60-90 minutes and includes mindfulness practices such as breathing awareness, body scan, emotional awareness, stress response awareness, and mindfulness in daily life. Sessions will be delivered through a combination of face-to-face and online formats.
- No Intervention: Control GroupParticipants in this arm will receive no intervention during the study period and will continue with their usual care. They will complete the same outcome assessments as the intervention group at baseline and at the end of the study.
Primary Outcome Measure
Change in Hot Flash Frequency and Severity [ Time Frame: Baseline and 8 weeks ]
Find similar trials
Related Studies
- Solifenacin Compared to Clonidine for Reducing Hot Flashes Among Breast Cancer PatientsPHASE2 · Recruiting · University of Arkansas · Little Rock, Arkansas
- Apple Women's Health StudyRecruiting · Apple Inc. · Boston, Massachusetts
- Autonomic Regulation of Blood Pressure in Premature and Early Menopausal WomenRecruiting · University of Minnesota · Minneapolis, Minnesota
- Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)PHASE3 · Recruiting · Vanda Pharmaceuticals · Los Angeles, California